MENU
+Compare
TEVJF
Stock ticker: OTC
AS OF
May 28 closing price
Price
$17.80
Change
-$1.51 (-7.82%)
Capitalization
9.29B

TEVJF stock forecast, quote, news & analysis

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world... Show more

TEVJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for TEVJF with price predictions
Jul 11, 2025

TEVJF sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for TEVJF moved above the 200-day moving average on July 10, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TEVJF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.146) is normal, around the industry mean (62.813). P/E Ratio (23.697) is within average values for comparable stocks, (89.433). TEVJF's Projected Growth (PEG Ratio) (6.078) is slightly higher than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.124) among similar stocks. P/S Ratio (0.599) is also within normal values, averaging (19.385).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

TEVJF paid dividends on December 12, 2017

Teva Pharmaceutical Industries Ltd. TEVJF Stock Dividends
А dividend of $0.09 per share was paid with a record date of December 12, 2017, and an ex-dividend date of November 28, 2017. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 3.81B. The market cap for tickers in the group ranges from 246 to 77.48B. ZTS holds the highest valuation in this group at 77.48B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 53%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 72%. INNPF experienced the highest price growth at 10,170%, while MSTH experienced the biggest fall at -51%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was -15% and the average quarterly volume growth was -9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 67
Price Growth Rating: 50
SMR Rating: 83
Profit Risk Rating: 91
Seasonality Score: 9 (-100 ... +100)
View a ticker or compare two or three
TEVJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
124 Dvora HaNevi’a Street
Phone
+972 39148213
Employees
36826
Web
https://www.tevapharm.com